title: Success of immunomodulators in MS shifts discovery focus to neuroprotection.
authors: Asher
authors: A
authors: Mullard
mesh_terms: D017322:Clinical Trials, Phase II as Topic / Q000639:trends; D017326:Clinical Trials, Phase III as Topic / Q000639:trends; D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000473:pathology / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D018696:Neuroprotective Agents